Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)

IMG_1960
Market Cap:
$145.38M

Outstanding Shares: 74.17M

Float: 69.54M


Analysis:  Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)’s latest press release responds to Silence Therapeutics plc becoming the new minority stakeholder of the company by now holding 6,000,359 Arrowhead shares. ARWR will remain focused on their company goals as the company has been bullish since mid-December.


Recent News:

Arrowhead Pharmaceuticals, Inc. (ARWR) today responded to the announcement by Silence Therapeutics plc that it acquired, in the open-market, an equity stake of 6,000,359 Arrowhead shares, representing 8.4% of the common shares outstanding. Arrowhead was advised of this just prior to the announcement by Silence. Continue Reading


UPTICK Newswire LLC is not an investment advisor. Investors are strongly encouraged to do their own due diligence and review all company documents and press releases to ensure the company noted above fits their own investment qualifications.

Source: Uptick Newswire

Related Post